AstraZeneca Pharma shares zoom nearly 11%

PTI | | Updated on: Dec 06, 2021

Shares of AstraZeneca Pharma India today surged nearly 11 per cent after the company received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the treatment of ovarian and breast cancer.

The stock soared 7.63 per cent to end at Rs 1,840.75 on BSE. During the day, it zoomed 10.74 per cent to Rs 1,894 -- its 52-week high.

At NSE, shares of the company jumped 10.63 per cent to settle at Rs 1,890.

The permission from the DCGI is for olaparib (Lynparza) tablets in the strengths of 100 mg and 150 mg, AstraZeneca Pharma India said in a BSE filing yesterday.

The tablets are a patented product of the AstraZeneca group, it added.

Published on August 17, 2018
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you